RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells
Go back to RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.72 +0.01 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.71 | 52 Week High | $16.54 | |||
| Open | $0.74 | 52 Week Low | $8.10 | |||
| Day High | $0.77 | P/E | N/A | |||
| Day Low | $0.70 | EPS | $0.00 | |||
| Volume | 581,329 | |||||
